title: Canadian patients with chronic hepatitis B cannot access appropriate drug treatments: a call for change.
authors: Morris
authors: M
authors: Sherman
authors: Samuel S
authors: SS
authors: Lee
mesh_terms: D000225:Adenine / Q000031:analogs & derivatives* / Q000191:economics / Q000627:therapeutic use; D000998:Antiviral Agents / Q000191:economics / Q000627:therapeutic use*; D002170:Canada; D017277:Drug Approval; D006147:Guanine / Q000031:analogs & derivatives* / Q000191:economics / Q000627:therapeutic use; D006297:Health Services Accessibility / Q000331:legislation & jurisprudence; D019694:Hepatitis B, Chronic / Q000188:drug therapy* / Q000191:economics; D006801:Humans; D019458:Insurance Coverage / Q000191:economics / Q000331:legislation & jurisprudence; D019259:Lamivudine / Q000191:economics / Q000627:therapeutic use; D008103:Liver Cirrhosis / Q000188:drug therapy; D009313:National Health Programs; D063065:Organophosphonates / Q000191:economics / Q000627:therapeutic use*; D000068698:Tenofovir
chemical_list: D000998:Antiviral Agents; D063065:Organophosphonates; D019259:Lamivudine; C413685:entecavir; D006147:Guanine; D000068698:Tenofovir; D000225:Adenine